HLS Therapeutics reported its third-quarter earnings for 2025, revealing a decrease in revenue compared to the previous year. The company’s earnings per share (EPS) fell short of expectations, ...
HLS Therapeutics Inc (TSX:HLS) presented its fiscal 2025 results on March 12, 2026, showcasing a significant operational turnaround despite missing fourth-quarter earnings expectations. While the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results